Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
miR-302a/b/d-3p Differentially Expressed During Frontonasal Development Is Sensitive to Retinoic Acid Exposure, Chihiro Iwaya, Akiko Suzuki, Goo Jun, et al.
Systems Neuroimmunology: Current Bottlenecks, Research Priorities and Future Directions, Harini Iyer, Christophe Benoist, Staci D Bilbo, et al.
Unveiling the Genetic Landscape of Coronary Artery Disease Through Common and Rare Structural Variants, Kruthika R Iyer, Shoa L Clarke, Rodrigo Guarischi-Sousa, et al.
Safety and Activity of CTX130, a CD70-Targeted Allogeneic CRISPR-Cas9-Engineered Car T-Cell Therapy, in Patients With Relapsed or Refractory T-Cell Malignancies (Cobalt-Lym): A Single-Arm, Open-Label, Phase 1, Dose-Escalation Study, Swaminathan P Iyer, R Alejandro Sica, P Joy Ho, et al.
Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial, Wissam A Jaber, Carin F Gonsalves, Stefan Stortecky, et al.
Racial and Ethnic Disparities in Neoadjuvant Chemotherapy Patterns and Outcomes in Early-Stage HER2-Positive Breast Cancer, Inimfon Jackson, Xiudong Lei, Hui Zhao, et al.
Perceived Prejudice or Discrimination in Medical Care Among US Adults, Inimfon Jackson, Robert Yu, Joël Fokom Domgue, et al.
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers, Jamaal C Jackson, Darren Sanchez, Aron Y Joon, et al.
Comprehensive Analysis of the Tumor Targeting Efficiency of Functionalized Nanoparticles in an Immunocompetent Environment, Nolan Jackson, Nasry Bouzeineddine, Daniel Cecchi, et al.
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer, Joan Jacob, Yasuaki Anami, Peyton C High, et al.
Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer, Luisa E Jacomina, David M Swanson, Melissa P Mitchell, et al.
Trends in Ischemic Stroke Hospitalization and Outcomes in the United States Pre- and Peri-COVID-19 Pandemic: A National Inpatient Sample Study, Alibay Jafarli, Mario Di Napoli, Rachel S Kasper, et al.
Soluble Immune Factor Profiles in Blood and CSF Associated With LRRK2 Mutations and Parkinson's Disease, Roshni Jaffery, Yuhang Zhao, Sarfraz Ahmed, et al.
Effects of Prebiotic Phytocompound Administration in Gestational Diabetic Dams and Its Influence on Offspring Cognitive Outcomes, Gayathri Jagadeesan, Tushar K Das, Jennifer M Mendoza, et al.
Evaluation of Enzyme Activity Predictions for Variants of Unknown Significance in Arylsulfatase A, Shantanu Jain, Marena Trinidad, Thanh Binh Nguyen, et al.
Lifelong Aortic Risk in Turner Syndrome: Unexpected Aortic Events in Asymptomatic Patients, Milan Jaiswal, Sara Mansoorshahi, Sharon Zachariah, et al.
Genomic and Phenotypic Correlates of Mosaic Loss of Chromosome Y in Blood, Yasminka A Jakubek, Xiaolong Ma, Adrienne M Stilp, et al.
Immunogenomic Determinants of Exceptional Response to Immune Checkpoint Inhibition in Renal Cell Carcinoma, Tejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Inhibiting Monocyte Migration Reduces Arterial Thrombosis and Facilitates Thrombolysis, Hee Jeong Jang, Jiwon Kim, Ha Kim, et al.
Case Report: Rare Intraventricular H3 K27-Altered Diffuse Midline Glioma in an Adult, Merari Jasso, Jay-Jiguang Zhu, Meenakshi B Bhattacharjee, et al.
Sequencing-Based Detection of Measles in Wastewater: Texas, January 2025, Sara Javornik Cregeen, Michael J Tisza, Blake Hanson, et al.
A Phase 2 Study of CPX-351 in Combination With Venetoclax in Patients With Newly Diagnosed High-Risk Acute Myeloid Leukemia, Wei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.
Optimizing Lower Intensity Triplet Therapy in Acute Myeloid Leukemia: A Practical Guide, Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies, Wei-Ying Jen, Sanam Loghavi, Alexandre Bazinet, et al.
Long-Term Follow-Up of a Phase 2 Study of All-Trans Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin in Acute Promyelocytic Leukemia, Wei-Ying Jen, Jennifer Marvin-Peek, Hagop M Kantarjian, et al.